– GEN’s Editor-in-Chief John Sterling inteviews Jeffrey Janus, President, and Jeff Krstich, CEO, of International Stem Cell Corporation.

Previous articleVentana Rebuffs Roche’s $3B Acquisition Proposal
Next articleActoGeniX Awarded $4.2M to Advance Oral Delivery of Biopharmaceuticals